Related Experiment Video
Updated: May 22, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Hepatic fibrosis in paediatric liver disease
Imeke Goldschmidt1, Ulrich Baumann
1Hannover Medical School, Childreńs Hospital, Division of Paediatric Gastroenterology and Hepatology, Carl Neuberg Street 1, 30519 Hannover, Germany.
Abstract:
Liver fibrosis is the common endpoint of chronic liver disease of variable aetiology. Liver injury induces excess deposition of extracellular matrix via inflammatory pathways, which in turn results in distortion of the vascular liver architecture. The two features combine to cause portal hypertension and reduced hepatocellular function. Diagnosis of liver fibrosis is made by liver biopsy, but non invasive tests like serological markers or elastographic methods are increasingly being recognized as useful tools in the diagnosis of fibrosis. Treatment options that exceed the treatment of the underlying liver disease are still largely experimental.
Related Concept Videos
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cirrhosis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
